TerrAscend (TSNDF) Profit After Tax (QoQ) (2021 - 2026)
TerrAscend (TSNDF) Profit After Tax (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.91 Bn | 88.04 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.17 Bn | 1.97 Bn |
| 3 | Zoetis | 32.54 Bn | 30.60 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.05 Bn | 20.89 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.82 Bn | 16.50 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | TerrAscend | 168.49 Mn | 168.02 Mn | 34.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -325.47% |
| Dec 31, 2025 | 134.48% |
| Sep 30, 2025 | 79.41% |
| Jun 30, 2025 | -292.10% |
| Mar 31, 2025 | -153.74% |
| Dec 31, 2024 | 198.02% |
| Sep 30, 2024 | -273.43% |
| Jun 30, 2024 | 58.00% |
| Mar 31, 2024 | 68.09% |
| Dec 31, 2023 | -451.53% |
| Sep 30, 2023 | 37.38% |
| Jun 30, 2023 | 40.81% |
| Mar 31, 2023 | -269.58% |
| Dec 31, 2022 | 104.47% |
| Sep 30, 2022 | -2,222.31% |
| Jun 30, 2022 | 203.00% |
| Mar 31, 2022 | -2,564.16% |
| Dec 31, 2021 | -98.97% |
| Sep 30, 2021 | 277.52% |
| Jun 30, 2021 | -117.28% |